Clinical trial
Antibiotics to Reduce Chorioamnionitis-Related Perinatal HIV Transmission
NCT00021671 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00021671 |
|---|---|
| Title | Antibiotics to Reduce Chorioamnionitis-Related Perinatal HIV Transmission |
| Official title | Phase III Trial of Antibiotics to Reduce Chorioamnionitis-Related Perinatal HIV Transmission |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Collaborators | National Institute of Mental Health (NIMH) NIH National Institute on Drug Abuse (NIDA) |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Erythromycin, Nevirapine, Ampicillin sodium, Metronidazole |
| Enrollment | 3,720 |
| Completion | Nov 1, 2004 |
| First posted | Aug 31, 2001 |
| Last update posted | Nov 1, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: